Precigen (PGEN)
(Delayed Data from NSDQ)
$0.97 USD
+0.03 (3.31%)
Updated Sep 9, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Precigen, Inc. (PGEN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.00 | $7.00 | $4.00 | 518.56% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Precigen, Inc. comes to $6.00. The forecasts range from a low of $4.00 to a high of $7.00. The average price target represents an increase of 518.56% from the last closing price of $0.97.
Analyst Price Targets (3 )
Broker Rating
Precigen, Inc. currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.80 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, four are Strong Buy, representing 80% of all recommendations. A month ago, Strong Buy represented 80%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/PGEN.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/15/2024 | JMP Securities | Jason N Butler | Strong Buy | Strong Buy |
6/3/2024 | H.C. Wainwright & Co. | Swayampakula Ramakanth | Strong Buy | Strong Buy |
5/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/22/2024 | Cantor Fitzgerald & Co | Jennifer Kim | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $6.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 253 |
Current Quarter EPS Est: | -0.08 |
PGEN FAQs
Precigen, Inc. (PGEN) currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Precigen, Inc. (PGEN) is $6.00. The current on short-term price targets is based on 4 reports.
The forecasts for Precigen, Inc. (PGEN) range from a low of $4 to a high of $7. The average price target represents a increase of $518.56 from the last closing price of $.97.
The current UPSIDE for Precigen, Inc. (PGEN) is 518.56%
Based on short-term price targets offered by three analysts, the average price target for Precigen, Inc. comes to $6.00. The forecasts range from a low of $4.00 to a high of $7.00. The average price target represents an increase of 518.56% from the last closing price of $0.97.